A Comparison of Two Molecular Methods for Detecting CALR Mutations in Myeloproliferative Neoplasms

Area of Science:

• Hematology
• Molecular Diagnostics
• Oncology

Background:

• Myeloproliferative neoplasms (MPN) are clonal hematopoietic stem cell disorders.
• Key subtypes include polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF).
• CALR mutations are frequently found in ET and PMF, but not PV, often involving exon 9 frameshift mutations.

Purpose of the Study:

• To evaluate the efficacy of high-resolution melting (HRM) analysis for CALR mutation detection in Taiwanese MPN patients.
• To compare HRM performance against the established ipsogen CALR RGQ PCR method.

Main Methods:

• Sixty Taiwanese patients diagnosed with MPN were included in the study.
• CALR mutations were identified using high-resolution melting (HRM) analysis.
• HRM results were validated by sequencing and compared with ipsogen CALR RGQ PCR.

Main Results:

• HRM analysis successfully detected CALR mutations in 12.3% (8/65) of MPN patients, identifying specific mutations like p.L367fs*46 and p.K385fs*47.
• The detection rate for CALR mutations using HRM was up to 6.25%.
• HRM demonstrated 100% concordance with ipsogen CALR RGQ PCR results.

Conclusions:

• Both HRM analysis and ipsogen CALR RGQ PCR are feasible and reliable for CALR mutation detection in MPN.
• HRM analysis offers advantages including being time-saving, cost-effective, and requiring minimal personnel.
• HRM presents a practical alternative for molecular diagnostics in MPN.